Tokyo, Jan. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059974) titled 'Misleading Islet Markers in Cases Treated with Immunoglobulin Therapy' on Jan. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Chiba University
Condition:
Condition - Diseases treated with immunoglobulin therapy, such as myasthenia gravis and idiopathic thrombocytopenic purpura
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to determine the proportion of patients who become positive for islet-related autoantibodies after immunoglobulin administration by measuring islet-related autoantibodies (GAD antibody, IA-2 antibody, insu...